Inventive step in patents: a European perspective

Published on August 29, 2019   41 min

Other Talks in the Category: Methods

0:00
Hello, my name is Dr. Jonathan Atkinson from HGF limited in Leads and I am a European patent attorney specializing in the field of pharmaceuticals. I have a degree and a doctorate in chemistry from Oxford University and my doctoral thesis concerned the synthesis of chiral derivatives of morphine-type alkaloids in a stereo selective manner. In addition to being a UK and European patent attorney, I'm also a fellow of the Royal Society of Chemistry. Today I'm going to talk about the concept of inventive step in the field of patents.
0:32
Before I delve into the concept of inventive step, I'm going to provide a little introduction to the background regarding the nature of the patent system itself. A patent is normally granted for a maximum of 20 years apart from certain exceptions in the pharmaceutical industry which allow for a longer patent term. This is to compensate for regulatory delays. All granted patents need to be renewed annually by payment of renewal fees to the national patent offices. Patents are granted for novel and inventive, i.e non-obvious subject matter, and are intended to protect the practical application of the concept or idea which is the subject of the patent. The patent only has effect in the country in which it was granted. The scope of protection afforded by a patent is defined in the language of the claims which can be found at the end of the patent's specification. The patent claims are very important.
Hide

Inventive step in patents: a European perspective

Embed in course/own notes